Steven Young

Acting Head of Medicinal Chemistry at BeiGene Ltd.

Steven Young

Steven Young

Acting Head of Medicinal Chemistry at BeiGene Ltd.

Biography

* 28 years of medicinal chemistry pharmaceutical R&D experience
* Led chemistry research teams that delivered the widely prescribed HIV drugs efavirenz and raltegravir to AIDS patients
* Former VP and Head of Medicinal Chemistry at Merck’s West Point laboratory
* Delivered numerous compounds across a wide range of therapeutic areas into Phase I, II and III clinical programs
* Ph.D. in Organic Chemistry from the University of California at Berkeley
* B.S. from Stevens Institute of Technology

Overview
RelSci Relationships

50

Number of Boards

2

Relationships
RelSci Relationships are individuals Steven Young likely has professional access to. A relationship does not necessarily indicate a personal connection.

Director at National Institute of Biological Sciences

Relationship likelihood: Strong

Co-Founder at BeiGene Ltd.

Relationship likelihood: Strong

Head of Biologics at BeiGene Ltd.

Relationship likelihood: Strong

Head of Discovery Biology at BeiGene Ltd.

Relationship likelihood: Strong

Research Head of Chemistry at BeiGene Ltd.

Relationship likelihood: Strong

Head of Molecular Sciences at BeiGene Ltd.

Relationship likelihood: Strong

President, Chief Executive Officer & Director at Agios Pharmaceuticals, Inc.

Relationship likelihood: Strong

Chief, Melanoma & Immunotherapeutics Service at Memorial Sloan-Kettering Cancer Center

Relationship likelihood: Strong

Director, Lymphoma Program at Stanford Cancer Center

Relationship likelihood: Strong

Head of Discovery Biomarkers & in Vivo Pharmacology at Beigene (Beijing) Co. Ltd.

Relationship likelihood: Strong

Paths to Steven Young
Potential Connections via
Relationship Science
You
Steven Young
Acting Head of Medicinal Chemistry at BeiGene Ltd.
Career History
Acting Head of Medicinal Chemistry
Current

BeiGene Ltd. is a commercial-stage biopharmaceutical company, which engages in the development and commercialization of innovative molecularly targeted and immuno-oncology drugs for the treatment of cancer. It focuses on Zanubrutinib (BGB-3111), Tislelizumab (BGB-A317), and Pamiparib (BGB-290). The company was founded by Xiao Dong Wang and John V. Oyler on October 28, 2010 and is headquartered in Beijing, China.

Acting Head of Medicinal Chemistry
Current

Beigene (Beijing) Co. Ltd., a subsidiary of BeiGene Ltd., is a Chinese company located in Beijing. The firm develops pharmaceuticals.

Boards & Committees
Member, Scientific Advisory Board
Current

BeiGene Ltd. is a commercial-stage biopharmaceutical company, which engages in the development and commercialization of innovative molecularly targeted and immuno-oncology drugs for the treatment of cancer. It focuses on Zanubrutinib (BGB-3111), Tislelizumab (BGB-A317), and Pamiparib (BGB-290). The company was founded by Xiao Dong Wang and John V. Oyler on October 28, 2010 and is headquartered in Beijing, China.

Member, Scientific Advisory Board
Current

BeiGene (Beijing) Co., Ltd., part of BeiGene Ltd., is a company headquartered in Beijing, China, that develops pharmaceuticals.

Other Affiliations
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Steven Young. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Steven Young's profile does not indicate a business or promotional relationship of any kind between RelSci and Steven Young.